The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial.

Background: Diabetes affects 10.5% of adults globally, with type 2 diabetes accounting for 90-95% of cases. Achieving optimal glycemic control is crucial yet challenging, particularly with insulin therapy, where 30-50% of patients fail to meet treatment targets.

Intelligent Diabetes Telemonitoring for Patients on Insulin Therapy: A Randomized Controlled Trial Protocol.

Protocol for a three-arm randomized controlled trial investigating telemonitoring with decision support in insulin-treated people with type 2 diabetes.